生成基于人类 iPSC 的血脑屏障芯片

Overview

This protocol demonstrates the generation of a personalized microfluidic blood-brain barrier (BBB) using differentiated induced pluripotent stem cells (iPSCs) on an organ-on-chip platform. This technology allows for the prediction of central nervous system drug permeability and the study of neurological disorders.

Key Study Components

Area of Science

• Neuroscience
• Biomedical Engineering
• Drug Development

Background

• The blood-brain barrier is crucial for maintaining brain homeostasis.
• Personalized BBB chips can be derived from iPSCs of individuals with genetic neurological diseases.
• Understanding the BBB's role in health and disease is essential for advancing neurological research.
• Pharmaceutical companies can utilize this platform for drug screening.

Purpose of Study

• To create a fully human, personalized BBB-on-chip.
• To predict CNS drug permeability.
• To investigate the role of the BBB in neurological disorders.

Methods Used

• Seeding differentiated iPSCs on an organ-on-chip.
• Utilizing microfluidic technology for BBB modeling.
• Assessing drug penetrability through the BBB.
• Studying neurological disease mechanisms using personalized chips.

Main Results

• Successful generation of a personalized BBB chip.
• Demonstrated ability to predict drug permeability.
• Provided insights into the BBB's involvement in neurological diseases.
• Facilitated a platform for pharmaceutical drug screening.

Conclusions

• The personalized BBB chip is a valuable tool for neuroscience research.
• This method can enhance understanding of CNS drug delivery.
• It opens new avenues for studying neurological disorders.

Frequently Asked Questions